Gut microbiome markers in subgroups of HLA class II genotyped infants signal future celiac disease in the general

Patricia L Milletich1, Angelica P Ahrens1, Jordan T Russell1

  • 1Department of Microbiology and Cell Science, Institute of Food and Agricultural Sciences, University of Florida, Gainesville, FL, United States.

Insights

Early gut microbiome differences in infants may predict future celiac disease (CD). Researchers identified specific bacterial signatures in one-year-olds who later developed CD, offering insights into early disease markers.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Pediatrics

Background:

  • Gut microbiome dysbiosis is linked to celiac disease (CD), but specific microbial signatures and early developmental timelines remain unclear.
  • Studies on high-risk or diagnosed individuals limit understanding of early-life dysbiosis in the general population.

Purpose of the Study:

  • To investigate early gut microbial imbalances in infants that correlate with the future development of celiac disease (fCD).
  • To identify specific bacterial signatures in one-year-old infants who later receive a CD diagnosis.

Main Methods:

  • Analysis of stool samples from 1478 one-year-old infants from the prospective 'All Babies In Southeast Sweden' cohort.
  • Utilized a novel iterative control-matching algorithm to compare infants who later developed CD (fCD) with matched controls.
  • Validated microbial differences through 100 separate, iterative permutations of matched controls.

Main Results:

  • Identified nine core microbes with prevalence differences and seven differentially abundant bacteria between fCD infants and controls.
  • Demonstrated statistically significant bacterial signatures in fCD infants, robust against general population variability.
  • Confirmed the presence of gut microbial differences up to 19 years prior to CD diagnosis.

Conclusions:

  • Gut microbial differences are detectable in infants as early as one year of age and precede celiac disease diagnosis.
  • These findings highlight the potential of early-life gut microbiome analysis for identifying individuals at risk of developing celiac disease.
  • This research provides the first evidence of significant gut microbial variations in infancy associated with later CD diagnosis in a general population.